Skip to content

Clinical trials

Respiratory Tract Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: Canada Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20095
20102
20112
20122
20135
20145
20157
20165
20178
20183
20193
20203
20212
20223
20231
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated7
Recruiting6
Active, not recruiting4
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
Medicago10
Eli Lilly and Company3
Vertex Pharmaceuticals Incorporated3
Bellus Health Inc. - a GSK company2
Blueprint Medicines Corporation2
United Therapeutics2
University of Washington, the Collaborative Health Studies Coordinating Center2
Upstream Bio Inc.2
Altair Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases63
Lung Diseases41
Bronchial Diseases17
Respiratory Tract Infections16
Asthma15
Lung Diseases, Obstructive12
RNA Virus Infections12
Virus Diseases12
Influenza, Human11
Lung Neoplasms11

Trials

Showing 76 to 63 of 63. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.